Specialist Diabetes Services

27/08/2026

So lovely when you get appreciated by patients. This mean so much!!

06/08/2026

When a doctor takes time out of his busy schedule to write a feedback letter like this, it means soooo much. We often do what we do with no feedback ever. I do love my job!!!

26/07/2026

Why we don’t want to inject two different Insulins in the same location☺️

21/07/2026

Breakthrough T1D is aware of the recent 60 Minutes episode (and accompanying articles in The Age and Sydney Morning Herald) examining medical technology and reported safety concerns, including devices for type 1 diabetes (T1D).

Advances in T1D medical technology are evidence-based and have transformed the management of a lifelong autoimmune condition. For many, they are lifesaving.

Continuous glucose monitors (CGMs) provide real-time glucose information, alert people to dangerous high and low glucose levels, and help reduce the risk of serious complications. For many families, they also provide peace of mind, particularly overnight and for managing T1D in young children.

Insulin pumps remove the need for multiple daily injections and help improve blood glucose control, mealtime flexibility and quality of life.

When used together, CGMs and insulin pumps deliver the best outcomes for people with T1D. These benefits are supported by extensive clinical evidence and are reflected in Australian and international standards of care. They have improved the health and safety of millions of people with T1D around the world.

Our priority is to ensure all Australians with T1D are able to access the medical devices of their choosing, and our advocacy focus remains on expanding subsidised access to insulin pumps.

These barriers are an urgent concern for our community members.
We do recognise that no device is perfect, that issues with T1D medical technologies are frustrating and concerning, and that the T1D community needs continued breakthroughs to help make managing the condition easier and less burdensome.

If any of these stories have raised worries about using T1D medical technology, or if you experience issues with any T1D medical device, we encourage you to speak to your healthcare team and device manufacturer for advice.

19/07/2026

For all of our current customers using Dexcom G6 remember NDSS will discontinue the supply of this by 30th of September. Contact our clinic now to book an appointment to get yoir access changed.

14/07/2026

A cure is definitely getting closer!! Woohoo!!

T1D CURE RESEARCH NEWS:

This is exactly the kind of diabetes research update I love sharing.

Sana Biotechnology announced today that the first participant in its gene-edited islet cell transplant study is still producing insulin 14 months after transplant—without immunosuppressive drugs.

Now, before anyone asks... this is just one participant. We need to see these results repeated in many more people before we know if this approach can truly work.

But here's why this update matters: the transplanted islet cells are still alive, still functioning, and researchers found no detectable immune attack against them. Even when insulin production dipped around the one-year mark, it later recovered.

This is still early research. It is not a cure, and it's not something that will be available anytime soon.

But every milestone like this helps researchers answer another big question on the road toward a scalable cure for type 1 diabetes.

I'll keep following this study and breaking down the science as new data comes out. 🧡🩵

11/07/2026

What do you guys think about this product. Do you think it might be something you might be interested in?

Live Glucose Display: Connects to Dexcom, Libre, and Nightscout for real-time glucose readings and trend arrows. Multi-User Support: Monitor up to 6 users on one device — auto-cycle, tap to switch, or view all at once. Audible Alerts: Optional sound alerts for highs, lows, and no data help you sta...

10/07/2026

Love this animated description of the work of Insulin and the importance of the GLUT-4 Transporters.